Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study-Reference-Cited by-同舟云学术

Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study

Published:2024-07-04 Issue: Volume: Page:
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Magnoni Francesca,Bianchi Beatrice,Pagan Eleonora,Corso Giovanni,Sala Isabella,Bagnardi Vincenzo,Claudia Sangalli,Brancaccio Roberta,Bottazzoli Elisa,Boato Antony,Munzone Elisabetta,Dellapasqua Silvia,Fusco Nicola,Viviana Galimberti,Veronesi Paolo

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10549-024-07422-7.pdf

Reference56 articles.

1. Rechsteiner A, Dietrich D, Varga Z (2023) Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: a retrospective analysis. J Cancer Res Clin Oncol 149(8):4967–4978. https://doi.org/10.1007/s00432-022-04443-x

2. Caldarella A, Buzzoni C, Crocetti E, Bianchi S, Vezzosi V, Apicella P, Biancalani M, Giannini A, Urso C, Zolfanelli F, Paci E (2013) Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol 139(4):617–623. https://doi.org/10.1007/s00432-012-1365-1

3. Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V (2014) Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist 19(8):805–813. https://doi.org/10.1634/theoncologist.2014-0108

4. Han Y, Wang J, Xu B (2020) Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis. Breast 54:114–120. https://doi.org/10.1016/j.breast.2020.09.006

5. WHO (2019) Breast Tumours WHO Classification of Tumours, 5th Edition 2019. International Agency for Research on Cancer. Edited by the WHO Classification of Tumours Editorial Board, Lyon (France)